z-logo
open-access-imgOpen Access
Organelle-Partitioned Sugar–Rhodamine Diad for In Vivo Tumor Imaging
Author(s) -
Enkang Zhang,
Chaozhang Yu,
Hui Tang,
Yuntong Li,
Dongliang Zuo,
Rongshui Yang,
Chao Ma,
Jiayin Miao,
Pingguo Liu,
Xinhui Su
Publication year - 2020
Publication title -
acs omega
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.779
H-Index - 40
ISSN - 2470-1343
DOI - 10.1021/acsomega.0c02323
Subject(s) - sialic acid , organelle , lysosome , in vivo , fluorescence , chemistry , cell sorting , rhodamine , rhodamine 123 , cell , biochemistry , biophysics , microbiology and biotechnology , cancer research , biology , physics , quantum mechanics , multiple drug resistance , enzyme , antibiotics
Current tumor imaging agents are often limited by their liability to dissipate from tumor tissues. As cell sugar sorting enables exogenous sugars to be delivered into predetermined subcellular locations, we synthesized sialic acid (Sia) derivatives with rhodamine-X conjugated at C-9 ( ROX Sia), which hitchhikes cell sialic acid sorting to target tumor cell lysosomes, exhibiting pH-independent long-term probe retention in lysosomes. ROX Sia gives selective, bright, and endured fluorescence signals in subcutaneous tumors and orthotopic tumors in mice models. These results indicate the potential of ROX Sia as a lysosome-targeted optical agent for fluorescence-guided tumor resection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom